These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1578705)

  • 1. [Plasmapheresis therapy of myasthenia gravis].
    Sano M; Utsugisawa K; Tohgi H
    Nihon Rinsho; 1992 Jan; 50 Suppl():337-44. PubMed ID: 1578705
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasmapheresis for myasthenia gravis.
    Med Lett Drugs Ther; 1979 Jul; 21(15):64. PubMed ID: 470831
    [No Abstract]   [Full Text] [Related]  

  • 3. [Plasma exchange in myasthenia gravis].
    Redeker M; Meyer-Wahl L
    Nervenarzt; 1982 Dec; 53(12):729-32. PubMed ID: 7155236
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis.
    Dau PC; Lindstrom JM; Cassel CK; Denys EH; Shev EE; Spitler LE
    N Engl J Med; 1977 Nov; 297(21):1134-40. PubMed ID: 917042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scientific overview of myasthenia gravis and an assessment of the role of plasmapheresis.
    Tindall RS
    Prog Clin Biol Res; 1982; 106():113-42. PubMed ID: 6757936
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasmapheresis in myasthenia gravis: decline in antireceptor antibody without clinical improvement. Case report.
    Riley TL; Monaghan WP
    Mil Med; 1981 Oct; 146(10):724-5. PubMed ID: 6795542
    [No Abstract]   [Full Text] [Related]  

  • 7. Transient neonatal myasthenia gravis in a baby born to a mother with new-onset anti-MuSK-mediated myasthenia gravis.
    O'carroll P; Bertorini TE; Jacob G; Mitchell CW; Graff J
    J Clin Neuromuscul Dis; 2009 Dec; 11(2):69-71. PubMed ID: 19955986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunoadsorption--a new treatment of myasthenia gravis].
    Berning T; Krummenerl T; Glaser J; Paulus H; van Husen N
    Med Klin (Munich); 1988 Feb; 83(4):125-8. PubMed ID: 3285161
    [No Abstract]   [Full Text] [Related]  

  • 9. [Indications for plasmapheresis in myasthenia gravis ].
    de Crousaz G
    Ther Umsch; 1982 Jul; 39(7):537-40. PubMed ID: 7123506
    [No Abstract]   [Full Text] [Related]  

  • 10. [Myasthenia gravis; clinical aspects, pathophysiology and treatment].
    Oosterhuis HJ
    Ned Tijdschr Geneeskd; 1983 Sep; 127(39):1765-71. PubMed ID: 6314161
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasmapheresis in the treatment of myasthenia gravis.
    Lenzhofer R; Graninger W; Dittrich C; Mamoli B; Zeitlhofer J; Pateisky K
    Wien Klin Wochenschr; 1983 Apr; 95(8):266-71. PubMed ID: 6603717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous mixed lymphocyte reaction in patients with myasthenia gravis: correlation with disease activity.
    Greenberg SJ; Olanow CW; Dawson DV; Crane B; Roses AD
    J Immunol; 1984 Mar; 132(3):1229-36. PubMed ID: 6229579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmapheresis therapy in myasthenia gravis.
    Dau PC
    Muscle Nerve; 1980; 3(6):468-82. PubMed ID: 7453714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards antigen-specific apheresis of pathogenic autoantibodies as a further step in the treatment of myasthenia gravis by plasmapheresis.
    Zisimopoulou P; Lagoumintzis G; Kostelidou K; Bitzopoulou K; Kordas G; Trakas N; Poulas K; Tzartos SJ
    J Neuroimmunol; 2008 Sep; 201-202():95-103. PubMed ID: 18667243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Myasthenia gravis (1). Experimental myasthenia gravis--a tool for the study of the pathogenesis, diagnosis and treatment of myasthenia gravis].
    Heilbronn E
    Lakartidningen; 1978 Oct; 75(41):3663-4, 3669. PubMed ID: 692231
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasmapheresis in myasthenia gravis.
    Dau PC
    Prog Clin Biol Res; 1982; 88():265-85. PubMed ID: 7100216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Plasmapheresis without concomitant immunosuppression in myasthenia gravis. Report of a case].
    Marchiori PE; Scaff M; Mello EP; Trindade VS; de Assis JL
    Rev Hosp Clin Fac Med Sao Paulo; 1981 Dec; 36(6):278-81. PubMed ID: 7345534
    [No Abstract]   [Full Text] [Related]  

  • 18. Thymus changes in anti-MuSK-positive and -negative myasthenia gravis.
    Lauriola L; Ranelletti F; Maggiano N; Guerriero M; Punzi C; Marsili F; Bartoccioni E; Evoli A
    Neurology; 2005 Feb; 64(3):536-8. PubMed ID: 15699390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Assay of acetylcholine receptor antibodies in myasthenia gravis. A study of 329 sera (author's transl)].
    Morel E; Raimond F; Goulon-Goëau C; Berrih S; Vernet-Der-Garabedian B; Harb J; Bach JF
    Nouv Presse Med; 1982 May; 11(24):1849-54. PubMed ID: 7110933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acetylcholine receptor antibodies in the diagnosis and management of myasthenia gravis.
    Nicholson GA; Griffiths LR
    Clin Exp Neurol; 1981; 18():61-9. PubMed ID: 6926393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.